MIBITop 1 mg

Powder for Injectable Solution

Qualitative and Quantitative Composition

Each vial contains:

1 mg of Tetrafluoroborate of [tetrakis (1-isocyanide-2-methoxy-2-methylpropyl) copper(I)]

Indications

• Assessment of myocardial perfusion
• Tumor evaluation
• Detection of parathyroid adenomas

Presentation

Box with 6 glass vials